Today: 12 June 2026
Browse Category

NASDAQ:SDGR 10 January 2026

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Schrödinger will integrate Eli Lilly’s AI drug discovery platform, TuneLab, into its LiveDesign software, giving biotech teams direct access to Lilly’s predictive models. Revvity and Benchling also announced deals to offer TuneLab through their platforms. Lilly and Revvity will jointly fund access for select users, using federated learning to protect data. BigHat Biosciences will collaborate with Lilly to improve antibody developability models.
10 January 2026
····

Stock Market Today

  • Dollarama Stock Gains 11% in Month Amid Expansion Plans and Valuation Debate
    June 12, 2026, 9:34 AM EDT. Dollarama (TSX:DOL) stock rose about 11% over the past month, attracting renewed investor attention. Despite a 5.1% year-to-date decline, the stock trades near its CA$199 price target with an intrinsic value estimated at CA$211.38, suggesting potential undervaluation. Dollarama's aggressive international expansion includes launching Dollarcity stores in Mexico and acquiring Australia's largest discount retailer, aiming for multi-year revenue growth. However, the stock trades at a high price-to-earnings (P/E) ratio of 40.5x, well above industry peers, reflecting elevated growth expectations and valuation risks. Investors should weigh the bullish outlook against risks from international integration and supply chain challenges to gauge Dollarama's true investment potential.

Latest articles

Plug Power Shares Fall as 2026 Profit Path Faces Doubts

Plug Power Shares Fall as 2026 Profit Path Faces Doubts

12 June 2026
Plug Power shares closed at $2.83 after a seventh straight decline, underperforming major indexes, as investors await the outcome of the Project Gateway asset sale to Stream Data Centers by June 30, a deal expected to bring in at least $132.5 million and seen as the next key test for liquidity and turnaround hopes.
Park Ha Biological Technology Stock Surges Premarket as BYAH Volatility Grabs Traders

Park Ha Biological Technology Stock Surges Premarket as BYAH Volatility Grabs Traders

12 June 2026
Park Ha Biological Technology’s Nasdaq shares soared 128.57% to $2.40 in Friday premarket after closing down 15.32% at $1.05, capping a volatile week with no new company news; investors await regular-session trading and any SEC filing tied to the company’s $300 million shelf registration as dilution risk and extreme price swings remain central concerns.
Go toTop